Komori
Kidswell Bio (4584) · FactFirst stated

Quarterly Sales Fluctuations Driven by the Order and Delivery Timing of Filgrastim BS

First written in FY2021-Q1. . Latest entry: FY2021-Q1.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Earnings fluctuations due to deliveries and installations being concentrated in the second half of the fiscal yearA theme 48 companies write about · 49 as a headwind · 0 as a tailwind

The whole theme swung hardest in 2020: 10 of 32 companies on the "Worse" side.

1 other company's latest entry also says "First stated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 48 companies compared. The sentences above are computed from all 48.
Full recordFilings, disclosures and news, newest first
  1. FY2021-Q1First statedAnnual report

    「The delivery schedule for sales of filgrastim BS, which accounts for most of the group's revenue, is set according to order conditions, and delivery timing varies by fiscal year. Consequently, revenue for the cumulative first-quarter consolidated period decreased year on year, but there was no impact on the earnings forecast for the consolidated fiscal year.」

    Because delivery timing for filgrastim BS varies by fiscal year, quarterly revenue may fluctuate year on year, while the company explains that there is no impact on its earnings forecast for the consolidated fiscal year.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Kidswell Bio yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.